Patient Awareness, Attitudes, and Preventive Practices Related to Venous Thromboembolism in Multiple Myeloma: A Cross-Sectional Analysis - Top-Institutions - MDSpire

Patient Awareness, Attitudes, and Preventive Practices Related to Venous Thromboembolism in Multiple Myeloma: A Cross-Sectional Analysis

  • By

  • Rui Zhang

  • Yue Weng

  • Shuting Wu

  • Ting Liao

  • Ping Pan

  • Hongmei Gou

  • Wei Ding

  • Mingjiang Dong

  • Zhongwen Yang

  • April 24, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Hematology
    • Oncology
    • Thrombosis Research

  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Hematology
    • Oncology
    • Thrombosis

  • #3

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Hematology
    • Oncology
    • Thrombosis Research

  • #4

    University of Texas MD Anderson Cancer Center
    University of Texas MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Hematology
    • Oncology
    • Thrombosis

  • #5

    Fred Hutchinson Cancer Center
    Fred Hutchinson Cancer Center

    Seattle, WA

    Key Differentiators

    • Hematology
    • Oncology
    • Thrombosis Research

Original Source(s)

Patient Awareness, Attitudes, and Preventive Practices Related to Venous Thromboembolism in Multiple Myeloma: A Cross-Sectional Analysis

  • by Rui Zhang, Yue Weng, Shuting Wu, Ting Liao, Ping Pan, Hongmei Gou, Wei Ding, Mingjiang Dong, Zhongwen Yang

  • April 24, 2026

Related Content

An ASCO preview: What to watch for at cancer research’s big meeting

Efficacy of Quadruplet Therapy with Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone as Initial Treatment for High-Risk Multiple Myeloma Patients in China: Findings from a Multi-Center Real-World Study

Bone marrow hemodilution assessment in multiple myeloma MRD by next generation flow cytometry - a mini review